The global demand for Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Enzyme-Linked Immunosorbent Assay Testing is a testing method used to determine antibodies, hormones in the blood. The antibodies help in determining the type of infection in an affected individual. This is a screening test used to diagnose various conditions like HIV, viral infections, Lyme disease, etc. The testing is carried out by fusing a blood sample against an antigen-specific to the disease being tested for along with an enzyme. The colour intensity of the mixture determines the concentration of antibodies in the patient being tested. These tests can also be used to determine food allergens. There are different types of ELISA tests based on the type of bonding between antibodies and enzymes.
The growing number of novel diseases affecting the global population and the need for early diagnosis will be the major drivers for the ELISA testing market. The use of this testing method for diagnostic and quality control will further accelerate the demand in the pharmaceutical industry. The need for allergen testing in foods due to the growing health-conscious population will further boost this market. Emerging laboratory automation and the need for biomarkers in drug formulation will augment the growth of this market. ELISA testing is a fast and efficient method for early detection of viral infections and hence its market is expected to grow at an alarming rate during COVID-19 pandemic. The main challenges associated with this testing market is the lack of awareness of testing techniques and the need for a suitable antigen recognised by the antibody.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of enzyme-linked immunosorbent assay (ELISA) testing.
The entire enzyme-linked immunosorbent assay (ELISA) testing market has been sub-categorized into test type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Test Type
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
- Vaccine Development
- Drug Monitoring & Pharmaceutical Industry
This section covers regional segmentation which accentuates on current and future demand for enzyme-linked immunosorbent assay (ELISA) testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the enzyme-linked immunosorbent assay (ELISA) testing market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., ALPCO, BioLegand, Inc., Enzo Life Sciences, Inc., Zeus Scientific, Inc., Shenzen YHLO Biotech Co. Ltd., Ortho-Clinical Diagnostics, Inc., R & D Systems Inc., BD Biosciences. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.